International organisations and non-governmental organisationsYou are hereOur regionInternational organisations
Western Switzerland accommodates numerous international and non-governmental organisations whose mission resides in designing the future of humanity. In addition to the United Nations, the region has the biggest organisations related to:
- trade (WTO)
- humanitarian (UNHCR, ICRC)
- sports (IOC, UEFA, ITTF)
- environment and nature (WWF, IUCN)
- telecommunications (ITU)
- politics (UN)
- health (WHO)
- development (UNCTAD, UNDP)
- labour (ILO)
- research (CERN)
- intellectual property (WIPO)
The contributions of international organisations are important. Among the major advantages one can name:
- international presence
- stability and security
- information (statistics, analysis, etc.)
- scientific and industrial return, technological gains (access to particular components, for example, training of researchers)
- cultural diversity
There are many non-governmental organisations in Western Switzerland, working in all areas of civil society. The Geneva Welcome Centre's (CAGI) objective is to facilitate the
installation and integration in the Geneva and Lemanic region of
international civil servants, members of permanent missions, consulates,
NGOs, Multinational Corporations as well as their families
BioAlps World Visibitlity Package 201918.03.2019A yearly international programme for our affiliated companies to increase their visibility.
BioAlps World Visibitlity Package 2019A yearly international programme for our affiliated companies to increase their visibility.
Tolerys SATherapeutics & Diagnostics, Other
Tolerys SA is an early stage biotech company developing a novel anti-inflammatory immunotherapy named EFD BCG. This product is derived from BCG vaccine using a patented inactivation process.
Therapeutics & Diagnostics, Vaccines
Preclinical studies proved that EFD BCG relies on its unique capacity to induce regulatory T cells in several models of chronic inflammatory diseases and is associated with a favorable safety profile.
In parallel to preclinical R&D, Tolerys SA has developed EFD BCG's manufacturing process and is preparing a first-in-man clinical trial.